Whole-Exome Sequencing Reveals High Prevalence of Germline Alterations in Neuroendocrine Neoplasms
Journal of the National Comprehensive Cancer Network · 2025
DOI: 10.6004/jnccn.2025.7035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025. Verfasst von Vineeth Sukrithan und 11 weiteren Autor:innen. Beteiligte Einrichtung: 1The Ohio State University, Columbus, OH. Hauptthemen laut MEDLINE: Exome Sequencing, Neuroendocrine Tumors, Germ-Line Mutation, Genetic Predisposition to Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Beyond syndromic tumor-predisposing conditions, germline susceptibility to neuroendocrine neoplasms (NENs) is not well understood. Familial clustering of cases and the co-occurrence of additional malignancies in patients suggest that additional, thus far unrecognized, germline predispositions to NEN development may exist.
Methods
We conducted whole-exome sequencing of germline and somatic DNA from a prospective cohort of patients with NENs (n=144) treated at The Ohio State University. Gene ontology analysis was performed using the DAVID algorithm. Multiplex immunofluorescence (mIF) was conducted on samples with germline MUTYH (g MUTYH ) alterations. Clinical data from patients with g MUTYH alterations who were treated with immune checkpoint inhibition (ICI) were also abstracted.
Results
A total of 144 samples were sequenced, revealing 3,400 variants, including 75 pathogenic and 99 likely pathogenic. Pathogenic/likely pathogenic variants were found in 78% of patients (112/144), across 127 genes. Pathogenic variants alone were identified in 45% (65/144), across 57 genes. Recurrent alterations were detected in 37 genes (frequency, false discovery rate), including MEN1 (5%; 1.22E-17), MUTYH (5%; 0.003), PKD1 (5%; 0.003), ATP4A (4%; 0.04), and PAH (4%; 0.003). The 3 most commonly involved pathways were DNA repair (26%), cellular calcium signaling (14%), and epigenetic regulation (7%). g MUTYH alterations were associated with high somatic tumor mutational burden in 3 of 6 patients. Among 5 subjects with gMUTYH , 2 showed a high levels of CD3+ and CD11c+ immune infiltration on mIF. Separately, we reported 2 cases of g MUTYH -altered NENs with robust responses to ICI.
Conclusions
Approximately 45% of patients with NENs harbor pathogenic germline variants on whole-exome sequencing. A subset of patients with g MUTYH alterations demonstrate a high tumor mutational burden, rich immune infiltration, and significant responses to ICI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1The Ohio State University, Columbus, OH.
Förderung
- NCI NIH HHS
Zitieren
APA
Sukrithan, V., Boateng, I., Liyanarachchi, S., Jain, P., Buss, J., Parwani, A., Shah, M. H., Das, K., Yearsley, M., Konda, B., Brock, P., & Eisfeld, A. K. (2025). Whole-Exome Sequencing Reveals High Prevalence of Germline Alterations in Neuroendocrine Neoplasms. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2025.7035
Vancouver
Sukrithan V, Boateng I, Liyanarachchi S, Jain P, Buss J, Parwani A, et al. Whole-Exome Sequencing Reveals High Prevalence of Germline Alterations in Neuroendocrine Neoplasms. Journal of the National Comprehensive Cancer Network. 2025. doi:10.6004/jnccn.2025.7035
BibTeX
@article{Sukrithan2025,
author = {Sukrithan, Vineeth and Boateng, Isaiah and Liyanarachchi, Sandya and Jain, Prachi and Buss, Jill and Parwani, Anil and Shah, Manisha H and Das, Komal and Yearsley, Martha and Konda, Bhavana and Brock, Pamela and Eisfeld, Ann-Kathrin},
title = {Whole-Exome Sequencing Reveals High Prevalence of Germline Alterations in Neuroendocrine Neoplasms},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
doi = {10.6004/jnccn.2025.7035}
}
EUVIMED